Skip to main content
SpringerLink
Log in
Book cover

Psychotropic Agents

Part II: Anxiolytics, Gerontopsychopharmacological Agents, and Psychomotor Stimulants

  • Book
  • © 1981

Overview

Editors:
  1. F. Hoffmeister

    1. Institut für Pharmakologie, Bayer AG, Wuppertal 1, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. G. Stille

    1. Institut für Arzneimittel des Bundesgesundheitsamtes, Berlin 30, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Handbook of Experimental Pharmacology (HEP, volume 55 / 2)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (17 chapters)

  1. Front Matter

    Pages I-XXVI
    Download chapter PDF

  2. Anxiolytics

    1. Front Matter

      Pages 1-1
      Download chapter PDF

    2. The Chemistry of Anxiolytics

      • L. H. Sternbach
      Pages 3-12

    3. General Pharmacology and Neuropharmacology of Benzodiazepine Derivatives

      • W. Haefely, L. Pieri, P. Polc, R. Schaffner
      Pages 13-262

    4. General Pharmacology and Neuropharmacology of Propanediol Carbamates

      • W. Haefely, R. Schaffner, P. Polc, L. Pieri
      Pages 263-283

    5. Behavioral Pharmacology of Anxiolytics

      • P. B. Dews
      Pages 285-292

    6. Biochemical Effects of Anxiolytics

      • C. Braestrup
      Pages 293-319

    7. Pharmacokinetics and Metabolism of Anxiolytics

      • S. A. Kaplan, M. L. Jack
      Pages 321-358

    8. Toxicology and Side-Effects of Anxiolytics

      • L. R. Hines
      Pages 359-393

    9. Dependence-Producing Effects of Anxiolytics

      • T. Yanagita
      Pages 395-406

  3. Gerontopsychopharmacological Agents

    1. Front Matter

      Pages 407-407
      Download chapter PDF

    2. Chemistry of Gerontopsychopharmacologic Agents

      • H. Hauth
      Pages 409-434

    3. Pharmacologic Approaches to Gerontopsychiatry

      • D. M. Loew, J. M. Vigouret
      Pages 436-459

    4. Experimental Behavioral Pharmacology of Gerontopsychopharmacological Agents

      • C. Giurgea, G. Greindl, S. Preat
      Pages 461-492

    5. Cerebrovascular Agents in Gerontopsychopharmacotherapy

      • F. Hoffmeister, S. Kazda, F. Seuter
      Pages 493-532

    6. Biochemical Effects of Gerontopsychopharmacological Agents

      • S. Hoyer
      Pages 533-542
Back to top

Keywords

About this book

This second volume continues the description of the psychotropic agents and discusses anxiolytics, gerontopsychopharmacological agents, and psychomotor stimulants. Of these groups of substances, most of this volume has been devoted to anxiolytics as the authors have endeavored to convey as complete a picture as possible. The editors are of the opinion that particular attention should be given to anxiolytics with regard to their range of administration as this is the most frequently prescribed group of psychotropic drugs. In contrast to neuroleptics and thymoleptics, anxiolytics are a class of psychotropic drugs whose therapeutic effect can be recognized in animal experiments to some extent. This, together with the analysis of the biochemical mechanisms of their actions, permits a better understanding of material processes in the brain accompanying the emotions: anxiety and tension. For the first time in the history of the Handbook the editors have devoted a whole chapter to gerontopsychopharmacological agents. In doing so they are also aware of the risk they are taking, at least from a pharmacological point of view, as gerontopsychopharmacological agents are an insufficiently defined and extremely heterogeneous group of substances. The only denominator the various subgroups of these agents have in common is that they are given in cases of dysfunctions, disorders, and diseases of the brain occurring mainly in the elderly.

Editors and Affiliations

  • Institut für Pharmakologie, Bayer AG, Wuppertal 1, Germany

    F. Hoffmeister

  • Institut für Arzneimittel des Bundesgesundheitsamtes, Berlin 30, Germany

    G. Stille

Bibliographic Information

  • Book Title: Psychotropic Agents

  • Book Subtitle: Part II: Anxiolytics, Gerontopsychopharmacological Agents, and Psychomotor Stimulants

  • Editors: F. Hoffmeister, G. Stille

  • Series Title: Handbook of Experimental Pharmacology

  • DOI: https://doi.org/10.1007/978-3-642-67767-0

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Berlin Heidelberg 1981

  • Softcover ISBN: 978-3-642-67769-4Published: 15 November 2011

  • eBook ISBN: 978-3-642-67767-0Published: 06 December 2012

  • Series ISSN: 0171-2004

  • Series E-ISSN: 1865-0325

  • Edition Number: 1

  • Number of Pages: XXVI, 780

  • Topics: Pharmacology/Toxicology, Pharmacy

Publish with us

Policies and ethics

Back to top

Search

Navigation